Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Investment Fund Ltd Bristol currently holds 2,582,108 shares of Genesis Biopharma, Inc (GNBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Investment Fund Ltd Bristol has been a net buyer of GNBP stock. They have purchased $988.2M and sold $5.4M worth of shares.
Investment Fund Ltd Bristol's most recent insider trade was on Dec 31, 2020, when they sold 183,493 shares at $2.28 per share.
Investment Fund Ltd Bristol serves as Executive at Genesis Biopharma, Inc (GNBP). They have executed 43 insider transactions totaling $993.6M over their tenure at the company.
Investment Fund Ltd Bristol holds the position of Executive at Genesis Biopharma, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
Investment Fund Ltd Bristol has shown a buying trading pattern, with $988.2M in total purchases and $5.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Investment Fund Ltd Bristol was on Mar 18, 2016, when they purchased $985.2M worth of RSSS shares. This transaction involved 36,244 shares at $27183.00 per share.
Investment Fund Ltd Bristol currently owns 2,582,108 shares of Genesis Biopharma, Inc (GNBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Investment Fund Ltd Bristol's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Investment Fund Ltd Bristol has 43 Form 4 filings on record as an insider at Genesis Biopharma, Inc.
Set alerts for Investment Fund Ltd Bristol and 40,000+ other insiders.